Omar Castaneda Puglianini

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Omar Castaneda Puglianini

Dec 31, 2024, 10:13 | Insight

Mahmoud Gaballa: Re outcomes of BCMA CART in CNS Multiple Myeloma

Mahmoud Gaballa, Assistant Professor in the department of Lymphoma and Myeloma at MD Anderson Cancer…

Dec 29, 2024, 16:39 | Science

Myeloma Paper of the Day, December 29th, suggested by Robert Orlowski

Robert Orlowski shared a post on X: “Myeloma Paper of the Day: BCMA-directed CAR T-cell therapy…

Dec 15, 2024, 10:14 | Insight

Ciara Freeman: How soluble BCMA quantification and MTV from SOC PET can predict tumor burden

Ciara Freeman, Assistant Member, Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer…

Jun 8, 2024, 15:44 | Insight

Myeloma Paper of the Day, June 8th, suggested by Robert Orlowski

Robert Orlowski shared on X: "Myeloma Paper of the Day: Patients with extramedullary myeloma have…

All: 4 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023